Literature DB >> 11018470

Activation of phospholipase D by PKC and GTPgammaS in human neuroblastoma cells overexpressing MARCKS.

S C Morash1, D M Byers, H W Cook.   

Abstract

Regulation of phospholipase D (PLD) activity participating in signal transduction involves complex interactions with small G-proteins (ARF, Rho) and protein kinase C isoforms (PKCalpha). In SK-N-MC human neuroblastoma cells, phorbol ester (TPA) activation of PLD was enhanced by overexpressing myristoylated alanine-rich C kinase substrate (MARCKS). To study MARCKS interactions with PLD, we investigated PLD isoform expression and activation by TPA and GTPgammaS in intact and digitonin-permeabilized clones transfected with MARCKS (M22). PLD2 was in both cytosol and membrane fractions while PLD1 was primarily membrane-associated in both vector control and M22 cells; location or quantities were unaltered by TPA treatment. TPA-stimulated PLD activity was higher in both intact and digitonin-permeabilized M22 cells than in vector controls. In contrast, GTPgammaS-stimulated PLD activity was independent of MARCKS expression but was additive with MARCKS-PKC-dependent activation in permeabilized cells. Combinations of PKC inhibition and down-regulation in intact and permeabilized (with GTPgammaS present) cells indicated that a PKC-mediated phosphorylation event was necessary in intact cells without access to GTPgammaS, stimulation of PLD mediated by GTPgammaS was independent of PKC, and PLD activation by PKC in permeabilized cells was kinase-independent. Western blot analysis showed that MARCKS, PKCalpha, PLD1 and PLD2 were present in a detergent-insoluble fraction (DIF); GTPgammaS increased recovery of PLD2 in DIF. Disruption of cholesterol-rich DIFs with digitonin, cyclodextrin or filipin potentiated activation of PLD by TPA. Our studies suggest that activation of PLD by PKC requires MARCKS and can involve both phosphorylation-independent and -dependent processes. As PLD activation by GTPgammaS is PKC-MARCKS-independent, MARCKS may provide a fine tuning component in conjunction with G-protein-mediated mechanisms for regulation of PLD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018470     DOI: 10.1016/s1388-1981(00)00094-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Expression of MARCKS effector domain mutants alters phospholipase D activity and cytoskeletal morphology of SK-N-MC neuroblastoma cells.

Authors:  Sherry C Morash; Donna Douglas; Christopher R McMaster; Harold W Cook; David M Byers
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

2.  MicroRNA-188 inhibits proliferation migration and invasion of prostate carcinoma by targeting at MARCKS.

Authors:  Yao Zhang; Wen Zhang; Aiming Xu; Ye Tian; Chao Liang; Zengjun Wang
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

3.  Myristoylated alanine-rich C kinase substrate (MARCKS) is involved in myoblast fusion through its regulation by protein kinase Calpha and calpain proteolytic cleavage.

Authors:  Sandrine Dulong; Sebastien Goudenege; Karine Vuillier-Devillers; Stéphane Manenti; Sylvie Poussard; Patrick Cottin
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

Review 4.  MARCKS and MARCKS-like proteins in development and regeneration.

Authors:  Mohamed El Amri; Una Fitzgerald; Gerhard Schlosser
Journal:  J Biomed Sci       Date:  2018-05-22       Impact factor: 8.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.